PHARMACOLOGICAL PROPERTIES OF SORBIDE DINITRATE

[1] BJERLOEV H, 1943, SVENSKA LAEKARTIDNIN, V40, P694

[2] BLISS C. I., 1938, QUART JOUR PHARM AND PHARMACOL, V11, P192

[3] BRADBURY JB, 1895, LANCET, V2, P1205

[4] FLODMARK S, 1943, SVENSKA LAKARTIDN, V40, P3057

[5] Forman S.E., 1941, J AM PHARM ASS SCI E, V30, P132, DOI [10.1002/jps.3030300504, DOI 10.1002/JPS.3030300504]

[6] GOLDBERG L, 1946, NORD MED, V29, P190

[7] Goodman L, 1941, PHARM BASIS THERAPEU

[8] Krantz JC, 1939, J PHARMACOL EXP THER, V67, P187

[9] Krantz JC, 1940, J PHARMACOL EXP THER, V70, P323

[10] Krantz JC, 1939, J PHARMACOL EXP THER, V67, P191

[1] BJERLOEV H, 1943, SVENSKA LAEKARTIDNIN, V40, P694

[2] BLISS C. I., 1938, QUART JOUR PHARM AND PHARMACOL, V11, P192

[3] BRADBURY JB, 1895, LANCET, V2, P1205

[4] FLODMARK S, 1943, SVENSKA LAKARTIDN, V40, P3057

[5] Forman S.E., 1941, J AM PHARM ASS SCI E, V30, P132, DOI [10.1002/jps.3030300504, DOI 10.1002/JPS.3030300504]

[6] GOLDBERG L, 1946, NORD MED, V29, P190

[7] Goodman L, 1941, PHARM BASIS THERAPEU

[8] Krantz JC, 1939, J PHARMACOL EXP THER, V67, P187

[9] Krantz JC, 1940, J PHARMACOL EXP THER, V70, P323

[10] Krantz JC, 1939, J PHARMACOL EXP THER, V67, P191